THC BioMed Intl Ltd Signs LOI to Purchase Kelowna, BC Based Supra Research and Development’s Cannabis Related Business

Vancouver, British Columbia–(Newsfile Corp. – November 17, 2015) – THC BioMed Intl Ltd (CSE: THC) (OTC Pink: THCBF) (FSE: TFHD) has signed a Letter of Intent to purchase Kelowna, British Columbia based Supra Research and Development’s cannabis related business.

Supra has an existing Dealer’s licence from Health Canada for the possession of cannabis and related active ingredients as well as for the production of extracts for the purpose of analysis.

InvestmentPitch.com has produced a “video news alert” which provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter “THC BioMed” in the search box.

Read full story at Stockhouse